vs
Assertio Holdings, Inc.(ASRT)与CuriosityStream Inc.(CURI)财务数据对比。点击上方公司名可切换其他公司
CuriosityStream Inc.的季度营收约是Assertio Holdings, Inc.的1.4倍($19.2M vs $13.5M),CuriosityStream Inc.同比增速更快(35.8% vs -57.9%),过去两年CuriosityStream Inc.的营收复合增速更高(26.5% vs -35.4%)
Assertio Therapeutics是一家美国专业制药企业,主要聚焦神经病学、疼痛以及中枢神经系统疾病领域的产品销售与推广。公司前身Depomed成立于1995年,总部位于加利福尼亚州纽瓦克,拥有多款获美国FDA批准的产品,目前在纳斯达克上市。
CuriosityStream是来自美国的流媒体订阅点播服务商,主打纪实类影视内容,涵盖纪录片长片、系列纪实节目与电视栏目。除了品牌同名的视频点播订阅服务外,该公司还开设了Curiosity纪实线性电视频道,目前已接入FuboTV、Roku频道等多个平台。
ASRT vs CURI — 直观对比
营收规模更大
CURI
是对方的1.4倍
$13.5M
营收增速更快
CURI
高出93.7%
-57.9%
两年增速更快
CURI
近两年复合增速
-35.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $13.5M | $19.2M |
| 净利润 | — | $-3.8M |
| 毛利率 | — | — |
| 营业利润率 | -86.7% | -17.6% |
| 净利率 | — | -19.7% |
| 营收同比 | -57.9% | 35.8% |
| 净利润同比 | — | -34.6% |
| 每股收益(稀释后) | $-4.54 | $-0.07 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ASRT
CURI
| Q4 25 | $13.5M | $19.2M | ||
| Q3 25 | $49.5M | $18.4M | ||
| Q2 25 | $29.2M | $19.0M | ||
| Q1 25 | $26.5M | $15.1M | ||
| Q4 24 | $32.2M | $14.1M | ||
| Q3 24 | $29.2M | $12.6M | ||
| Q2 24 | $31.1M | $12.4M | ||
| Q1 24 | $32.4M | $12.0M |
净利润
ASRT
CURI
| Q4 25 | — | $-3.8M | ||
| Q3 25 | $11.4M | $-3.7M | ||
| Q2 25 | $-16.4M | $784.0K | ||
| Q1 25 | $-13.5M | $319.0K | ||
| Q4 24 | — | $-2.8M | ||
| Q3 24 | $-2.9M | $-3.1M | ||
| Q2 24 | $-3.7M | $-2.0M | ||
| Q1 24 | $-4.5M | $-5.0M |
营业利润率
ASRT
CURI
| Q4 25 | -86.7% | -17.6% | ||
| Q3 25 | 23.2% | -24.5% | ||
| Q2 25 | -27.5% | 2.5% | ||
| Q1 25 | -50.0% | 0.5% | ||
| Q4 24 | -41.9% | -27.4% | ||
| Q3 24 | -10.4% | -25.8% | ||
| Q2 24 | -11.6% | -20.6% | ||
| Q1 24 | -13.4% | -30.4% |
净利率
ASRT
CURI
| Q4 25 | — | -19.7% | ||
| Q3 25 | 23.1% | -20.4% | ||
| Q2 25 | -56.0% | 4.1% | ||
| Q1 25 | -51.1% | 2.1% | ||
| Q4 24 | — | -19.9% | ||
| Q3 24 | -10.0% | -24.3% | ||
| Q2 24 | -11.8% | -16.4% | ||
| Q1 24 | -13.9% | -42.0% |
每股收益(稀释后)
ASRT
CURI
| Q4 25 | $-4.54 | $-0.07 | ||
| Q3 25 | $0.11 | $-0.06 | ||
| Q2 25 | $-0.17 | $0.01 | ||
| Q1 25 | $-0.14 | $0.01 | ||
| Q4 24 | $-3.28 | $-0.05 | ||
| Q3 24 | $-0.03 | $-0.06 | ||
| Q2 24 | $-0.04 | $-0.04 | ||
| Q1 24 | $-0.05 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $63.4M | $27.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $94.0M | $41.5M |
| 总资产 | $267.0M | $75.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
ASRT
CURI
| Q4 25 | $63.4M | $27.3M | ||
| Q3 25 | $93.4M | $27.8M | ||
| Q2 25 | $98.2M | $28.1M | ||
| Q1 25 | $87.3M | $33.4M | ||
| Q4 24 | $100.1M | $32.1M | ||
| Q3 24 | $88.6M | $33.2M | ||
| Q2 24 | $88.4M | $39.5M | ||
| Q1 24 | $80.7M | $38.8M |
总债务
ASRT
CURI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $38.6M | — |
股东权益
ASRT
CURI
| Q4 25 | $94.0M | $41.5M | ||
| Q3 25 | $105.8M | $47.2M | ||
| Q2 25 | $93.3M | $49.8M | ||
| Q1 25 | $108.5M | $58.1M | ||
| Q4 24 | $121.1M | $57.8M | ||
| Q3 24 | $130.5M | $62.2M | ||
| Q2 24 | $132.2M | $64.8M | ||
| Q1 24 | $134.5M | $67.0M |
总资产
ASRT
CURI
| Q4 25 | $267.0M | $75.7M | ||
| Q3 25 | $319.8M | $74.7M | ||
| Q2 25 | $273.8M | $78.7M | ||
| Q1 25 | $286.4M | $85.3M | ||
| Q4 24 | $284.7M | $86.2M | ||
| Q3 24 | $276.0M | $87.6M | ||
| Q2 24 | $279.4M | $90.9M | ||
| Q1 24 | $282.0M | $94.6M |
负债/权益比
ASRT
CURI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.29× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-30.0M | $4.0M |
| 自由现金流经营现金流 - 资本支出 | — | $3.9M |
| 自由现金流率自由现金流/营收 | — | 20.5% |
| 资本支出强度资本支出/营收 | — | 0.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
ASRT
CURI
| Q4 25 | $-30.0M | $4.0M | ||
| Q3 25 | $-4.8M | $4.4M | ||
| Q2 25 | $19.1M | $2.8M | ||
| Q1 25 | $-12.5M | $1.9M | ||
| Q4 24 | $11.5M | $3.0M | ||
| Q3 24 | $-35.0K | $2.3M | ||
| Q2 24 | $7.4M | $2.2M | ||
| Q1 24 | $7.5M | $666.0K |
自由现金流
ASRT
CURI
| Q4 25 | — | $3.9M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $1.8M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率
ASRT
CURI
| Q4 25 | — | 20.5% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 12.2% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度
ASRT
CURI
| Q4 25 | — | 0.1% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.5% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | 0.0% | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
现金转化率
ASRT
CURI
| Q4 25 | — | — | ||
| Q3 25 | -0.42× | — | ||
| Q2 25 | — | 3.56× | ||
| Q1 25 | — | 6.03× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASRT
| Products | $12.8M | 95% |
| Other | $719.0K | 5% |
CURI
暂无分部数据